ZYN vs. VELO: What's Actually Different?
ZYN and VELO are the two largest nicotine pouch brands in the world, and they’re owned by direct competitors: ZYN by Philip Morris International (which acquired Swedish Match in 2022), VELO by British American Tobacco. Here’s how they actually differ, beyond marketing.
Market position
ZYN dominates in the United States, holding roughly 63–70% of the US nicotine pouch market as of 2025. VELO has a stronger position in Europe and other international markets, where BAT has invested heavily in distribution. If you’re in the US, ZYN is far more likely to be on the shelf next to you; outside the US, VELO is often the more visible option.
Pouch format
ZYN uses a “dry” pouch format — it releases nicotine more slowly and feels less noticeable in the mouth, which is part of why it’s popular with people trying to use pouches more discreetly. VELO leans toward a slightly moister format in some of its lines, which tends to release nicotine faster but can feel less comfortable for extended wear.
Strength range
Both brands offer a range roughly from 3mg to around 10–11mg per pouch for their mainstream lines. Neither brand competes in the ultra-high-strength category (20mg+) the way smaller Nordic brands like White Fox, Pablo, or Killa do — ZYN and VELO are positioned for a broader, more moderate-strength audience.
Flavor range
ZYN offers a wider flavor lineup in the US market (around 21 flavors, largely mint, citrus, coffee, and fruit variations). VELO’s flavor range varies significantly by country due to differing local regulations — some EU countries restrict flavored nicotine pouches, so VELO’s lineup in, say, Denmark may look different from its lineup in the UK.
Regulatory status
This is the most substantive difference. As of January 2025, the FDA granted a Marketing Granted Order to 20 specific ZYN products, and in June 2026 authorized ZYN to carry a specific modified-risk claim relative to cigarettes — a first for the category. VELO has not received the equivalent US authorization for the same claim. This doesn’t mean VELO is somehow less legitimate; PMTA review is slow and brand-by-brand, and BAT has pursued its own regulatory filings on its own timeline. See our US legal status page for the details on what FDA authorization actually covers.
Bottom line
If you’re comparing the two as a consumer: ZYN tends to be the more discreet, slower-release option with the widest flavor selection in the US; VELO is more broadly available internationally and offers a slightly different mouthfeel. Neither is inherently “safer” than the other — both are made by companies with FDA-cleared or in-review manufacturing processes, and the health considerations that apply to nicotine pouches generally apply to both. See our health and safety overview for that discussion.